VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Sativa Wellness Group Inc. (CSE:SWEL)(AQSE:SWEL) (“Sativa Wellness” or the “Company“) wishes to announce a record month of sales in December.
We are pleased to advise that December 2020 was another record sales month for Sativa Wellness.
2020 was a transformational year for the company as we combined with Stillcanna Inc. to create a leading European seed to consumer company in the CBD wellness market. Having a fully integrated supply chain allows us to control both quality and costs. Producing a traceable high-quality product has never been more important than today as we approach the UK FSA Novel Food validation deadline at the end of March. Sativa is well prepared for this process and embraces a market with high quality, compliant products.
In 2021 our sights are on continuing to drive sales in the UK and truly extending our reach into Europe. We already have a strong presence in Europe with our extraction and production plant, and we are now extending our capabilities to sell and distribute our products in European markets.
All the best for a safe, healthy, happy and prosperous 2021.
Further information regarding the Company can be found under the Company’s profile on www.sedar.com.
On behalf of the Board of Directors,
Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release.
This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Stillcanna’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes” “plan is” or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur”, “will be achieved” or “shortly”. The forward-looking information and forward-looking statements contained herein include, but are not limited to information concerning the Company’s level of preparation for Novel Food validation by the UK FSA, Company objectives or targets for 2021, and plans to expand into Europe.
Although Sativa Wellness believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, expanding reach into Europe, and selling and distributing products in Europe in 2021. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
SOURCE: Sativa Wellness Group Inc.
View source version on accesswire.com: